The Importance of Molecular Testing in the Treatment of Cholangiocarcinoma
David Malka(Inserm), Peter Schirmacher(Heidelberg University), Joachim C. Mertens(GastroZentrum Hirslanden Zürich), Alexander Siebenhüner(University Hospital Zurich)
DOAJ (DOAJ: Directory of Open Access Journals)
November 1, 2020
Cited by 3
Related Papers
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
|New England Journal of Medicine|2018|2.9k
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
|Nature Reviews Gastroenterology & Hepatology|2020|2.5k
Senescence surveillance of pre-malignant hepatocytes limits liver cancer development
|Nature|2011|1.6k
Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
|Nature Reviews Gastroenterology & Hepatology|2016|1.4k
Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2018|1.1k